Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of investors ...

Mitch André Garcia considers the disputed discovery of element 104 and takes a look at how the chemistry of this synthetic element is developing. Rutherfordium, the 104th element on the periodic table ...